close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

MDT

99.78

+0.07%↑

A

146.88

+0.33%↑

VEEV

243.22

+1.79%↑

HQY

97.62

+0.6%↑

PHR.US

16.87

-3.16%↓

Strona główna・Stock List・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorHealthcare

30.46 0.99

Strong Buy

Price update 8 sty 2026, 16:22 UTC

BuySell

Overview

Share price change

24h

Current

Min

29.59

Max

30.88

Key metrics

By Trading Economics

Income

66M

-35M

Sales

70M

71M

Profit margin

-49.028

Employees

143

EBITDA

66M

-34M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+36.44% upside

Market Stats

By TradingEconomics

Market Cap

727M

2.9B

Previous open

29.47

Previous close

30.46

News Sentiment

By Acuity

50%

50%

166 / 372 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

12 / 13.14 Support & Resistance

VIRIDIAN THERAPEUTICS INC Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

7 sty 2026, 23:11 UTC

Earnings

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

DJ

Read

7 sty 2026, 22:55 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

DJ

Read

7 sty 2026, 21:39 UTC

Major Market Movers

Raytheon Down Following Trump Post Criticizing Company

DJ

Read

7 sty 2026, 20:13 UTC

Major Market Movers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

DJ

Read

7 sty 2026, 20:03 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

DJ

Read

7 sty 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

7 sty 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

DJ

Read

7 sty 2026, 23:42 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

DJ

Read

7 sty 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

DJ

Read

7 sty 2026, 23:29 UTC

Acquisitions, Mergers, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

DJ

Read

7 sty 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

DJ

Read

7 sty 2026, 22:46 UTC

Earnings

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

DJ

Read

7 sty 2026, 22:45 UTC

Earnings

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

DJ

Read

7 sty 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

DJ

Read

7 sty 2026, 22:42 UTC

Earnings

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

DJ

Read

7 sty 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

DJ

Read

7 sty 2026, 22:41 UTC

Earnings

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

DJ

Read

7 sty 2026, 22:40 UTC

Major Market Movers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

DJ

Read

7 sty 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

DJ

Read

7 sty 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

DJ

Read

7 sty 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

DJ

Read

7 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

7 sty 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

DJ

Read

7 sty 2026, 21:22 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

DJ

Read

7 sty 2026, 21:18 UTC

Acquisitions, Mergers, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

DJ

Read

7 sty 2026, 21:05 UTC

Acquisitions, Mergers, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

DJ

Read

7 sty 2026, 20:29 UTC

Acquisitions, Mergers, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

DJ

Read

7 sty 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

DJ

Read

7 sty 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

DJ

Read

7 sty 2026, 19:48 UTC

Major Market Movers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

DJ

Read

Peer Comparison

Price change

VIRIDIAN THERAPEUTICS INC Forecast

Price Target

By TipRanks

36.44% upside

12 Months Forecast

Average 41.71 USD  36.44%

High 61 USD

Low 14.212 USD

Based on 17 Wall Street analysts offering 12 month price targets forVIRIDIAN THERAPEUTICS INC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

17 ratings

17

Buy

0

Hold

0

Sell

Based on 17 analysts giving stock ratings to VIRIDIAN THERAPEUTICS INC - Dist in the past 3 months.

Technical Score

By Trading Central

12 / 13.14Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

166 / 372 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

99.78

↑ +0.07%

A

Agilent Technologies Inc

146.88

↑ +0.33%

VEEV

Veeva Systems Inc

243.22

↑ +1.79%

HQY

HealthEquity Inc

97.62

↑ +0.6%

PHR.US

Phreesia Inc

16.87

↓-3.16%
help-icon Live chat